Alexandros Fotopoulos - Feb 10, 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Technical Officer
Signature
/s/ Edgar Cale, Attorney-in Fact
Stock symbol
PASG
Transactions as of
Feb 10, 2022
Transactions value $
$0
Form type
4
Date filed
2/14/2022, 04:14 PM
Previous filing
May 19, 2021
Next filing
Jun 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PASG Common Stock 8.38K Feb 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Stock Option (right to buy) Award $0 +164K $0.00 164K Feb 10, 2022 Common Stock 164K $4.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2020 Employee Stock Purchase Plan purchases of 1,495 shares that occurred since the date of the Reporting Person's last ownership report.
F2 The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.